Advertisement

Topics

Cancer Genetics enters $16mm financing commitment concurrent with vivoPharm buy; gets $3mm up front

15:40 EDT 22 Aug 2017 | Elsevier Business Intelligence

Molecular diagnostics firm Cancer Genetics Inc. entered a financing agreement with Aspire Capital, through which Aspire will ...

Original Article: Cancer Genetics enters $16mm financing commitment concurrent with vivoPharm buy; gets $3mm up front

NEXT ARTICLE

More From BioPortfolio on "Cancer Genetics enters $16mm financing commitment concurrent with vivoPharm buy; gets $3mm up front"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...